Views & Analysis Imparare a convivere con la LHON Ogni paziente affronta il viaggio della vita a modo proprio, imparando a conoscere la malattia al meglio delle proprie possibilità e attraverso gli strumenti a disposizione.
News UK MHRA green lights AbbVie’s ELAHERE for ovarian cancer AbbVie has secured UK marketing authorisation for ELAHERE (mirvetuximab soravtansine), the first antibo
Market Access The value of a partner, globally and locally A new podcast looks at recent trends related to drug approvals, as well as challenges and opportunities both small and large pharma companies face